Gastrointestinal Cells
Our gastrointestinal cell portfolio includes primary human cell models derived from the stomach, small intestine, colon, rectum, and associated vascular and mesenteric tissues. These biologically relevant cells support research in gastrointestinal physiology, epithelial barrier function, intestinal inflammation, mucosal repair, motility disorders, angiogenesis, and gastrointestinal oncology.
The collection encompasses epithelial cells, fibroblasts, smooth muscle cells, microvascular endothelial cells, and tumor-associated vascular models, enabling researchers to investigate complex cellular interactions across the gastrointestinal microenvironment and disease-specific pathways.
5
Digestive Tract
Regions Represented
4
Major Cell
Compartments
20+
Primary Gastrointestinal
Cell Models
Filter By:
Our Gastrointestinal Cell Portfolio Highlights
Comprehensive Gastrointestinal Cell Resources
Our portfolio represents the major cellular compartments of the gastrointestinal tract, supporting studies from basic tissue biology to disease modeling.
-
Multi-Region Gastrointestinal Models
- Stomach, small intestine, colon, and rectum-derived cell types
- Region-specific epithelial, stromal, and vascular models
- Suitable for comparative gastrointestinal studies
-
Complete Tissue Microenvironment Coverage
- Epithelial cells, fibroblasts, and smooth muscle cells
- Microvascular and mesenteric endothelial cell populations
- Models supporting multicellular gastrointestinal systems
-
Disease-Relevant Cell Resources
- Colon carcinoma epithelial cells
- Tumor-associated endothelial cells
- Models for gastrointestinal cancer and vascular biology research
Gastrointestinal Research Support
We support investigations into digestive tract physiology, barrier integrity, tissue remodeling, vascular function, and gastrointestinal disease mechanisms.
-
Barrier Function and Mucosal Biology
Suitable for evaluating epithelial integrity, permeability, nutrient transport, host-environment interactions, and mucosal responses to injury.
-
Fibrosis and Tissue Remodeling Studies
Support for investigations involving fibroblast activation, extracellular matrix regulation, wound repair, and chronic inflammatory remodeling.
-
Motility and Smooth Muscle Research
Applicable for studying gastrointestinal contractility, smooth muscle physiology, and mechanisms underlying motility disorders.
-
Vascular and Tumor Microenvironment Applications
Useful for examining angiogenesis, endothelial function, tumor-associated vasculature, and stromal interactions within gastrointestinal cancers.
Which gastrointestinal cell types are most suitable for intestinal barrier studies?
Human intestinal epithelial cells, small intestinal epithelial cells, and stomach epithelial cells are commonly used to investigate epithelial integrity, permeability, nutrient transport, and mucosal responses to environmental or inflammatory stimuli.
How can researchers model the gastrointestinal microenvironment in vitro?
Combining epithelial cells with fibroblasts, smooth muscle cells, and microvascular endothelial cells enables the development of more physiologically relevant co-culture systems that better reflect tissue architecture and cell-cell interactions.
What cell models are commonly used to study intestinal fibrosis and tissue remodeling?
Intestinal fibroblasts, colonic fibroblasts, and mesenteric fibroblasts are valuable tools for investigating extracellular matrix deposition, fibroblast activation, wound healing, and chronic inflammatory remodeling processes.
Can these cells support gastrointestinal motility research?
Yes. Gastrointestinal smooth muscle cells derived from the stomach, intestine, and rectum are widely used to evaluate contractile activity, smooth muscle signaling pathways, and mechanisms associated with motility disorders.
What is the value of tumor-associated endothelial cells in gastrointestinal cancer studies?
Colon tumor-associated endothelial cells provide a relevant model for studying tumor angiogenesis, vascular remodeling, endothelial-cancer cell interactions, and the development of anti-angiogenic therapeutic strategies.